Results 201 to 210 of about 9,672 (236)

Blood Culture-Negative Cardiovascular Syphilis in an Untreated HIV-Positive Man. [PDF]

Am J Case Rep
Behjatnia H, Crespo A, Castillo Y, Dominguez L, Carlan SJ.   +4 more
europepmc   +1 more source

A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran. [PDF]

Cost Eff Resour Alloc
Jafari M, Mehdizadeh P, Keshavarz K, Teymourzadeh E, Abyazi MA, Alavian SM, Pouria A.   +6 more
europepmc   +1 more source

Continuity of long-term follow-up in patients with chronic hepatitis C after sustained virologic response following direct-acting antiviral therapy: a nationwide real-world multicenter cohort study in Japan. [PDF]

J Gastroenterol
Ohara M, Kozuka R, Uchida Y, Iino C, Sasaki R, Tojima H, Kawata K, Kakizaki S, Tokumoto Y, Endo M, Asai A, Inoue J, Nagata K, Takahashi H, Shimakami T, Ogawa K, Enomoto M, Ikegami T, Ide T, Sakamoto N, Korenaga M.   +20 more
europepmc   +1 more source

IFNL4 genotype and other personal characteristics to predict response to 8-week sofosbuvir-based treatment for chronic hepatitis C. [PDF]

J Infect
O'Brien TR, Witt DJ, Saxena V, Morrissey KG, Chen S, Baker FS, Prokunina-Olsson L, Pfeiffer RM, Lai JB.   +8 more
europepmc   +1 more source

Marked Reduction in HIV/HCV Coinfections in Iceland Following the TraP HepC Nationwide Hepatitis C Elimination Program. [PDF]

Open Forum Infect Dis
Hlynsdottir K, Olafsson S, Hernandez UB, Kristjansson M, Gottfredsson M.   +4 more
europepmc   +1 more source

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis [PDF]

New England Journal of Medicine, 2014
Kris V Kowdley, K Rajender Reddy, Eric Lawitz   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Ledipasvir/sofosbuvir

Reactions Weekly, 2018
  +13 more sources